Advertisement

MGLN

Magellan Health, Inc.

Healthcare

Set alert

Price alert · MGLN

All alert types
94.99 0.00 0.00%
As of Apr 24, 2025
94.99 Day range 94.99

52-week range unavailable

Open
95.00
Prev close
94.99
Mkt cap
2.50B
Vol
832.18K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
94.99
High
94.99
Forward P/E
27.86
Beta
1.04
Short ratio
9.84
Inst. own
102.61%
Dividend
0.00
Ex-div date
Earnings
Feb 25, 2022
50-d avg
94.68
200-d avg
94.47
1y target
95.00

2Y chart

Chart tools
Interval
MGLN two-year price chart92.694.396.097.799.4Nov 1Nov 12Nov 24Dec 8Dec 20Jan 3

Key statistics

Market cap
2.50B
Enterprise value
2.09B
Trailing P/E
8.49
Forward P/E
27.86
PEG ratio
-39.71
Price / sales
0.52
Price / book
1.29
EPS (TTM)
11.19
Beta
1.04
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
6.26%
Revenue (TTM)
4.82B
Revenue growth
7.20%
Free cash flow
689.85M
Total cash
1.01B
Total debt
562.64M
Return on equity
-0.16%
Shares outstanding
26.33M
Short % of float
5.71%
50-day average
94.68
200-day average
94.47

Analyst view

Consensus: hold

Hold
Price target (mean) 95.00
Ratings (0m) 4 2 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Feb 25, 2022

Expected Feb 25, 2022. Consensus EPS estimate 0.38.

Earnings history

Financials — quick view

All financials
MGLN Revenue — quarterly 1.25B
2017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 2021
MGLN Net income — quarterly 5.94M
2017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 2021
MGLN EPS — quarterly 0.03
2017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 2021

Earnings

MGLN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 25, 2022Dec 1, 20210.42———
Nov 5, 2021Sep 1, 20210.00———
Aug 5, 2021Jun 1, 20210.00———
Apr 30, 2021Mar 1, 20210.78———
Feb 26, 2021Dec 1, 2020-0.30———
Oct 29, 2020Sep 1, 2020-0.12———

Upgrades / downgrades

MGLN analyst upgrades and downgrades
DateFirmActionFromTo
Jan 15, 2021JefferiesdownBuyHold
Jan 6, 2021Stephens & Co.downOverweightEqual-Weight
Sep 10, 2020B of A Securitiesmain—Buy
Jul 30, 2020Jefferiesmain—Buy
Feb 22, 2019Bank of Americainit—Buy
Jan 14, 2019Stephens & Co.init—Equal-Weight

About Magellan Health, Inc.

Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.

Sector
Healthcare
Industry
Healthcare Plans
Country
United States

News

Your note

Sign in to keep a note on MGLN — it syncs with the Stock Master app.

Insider holders

MGLN insider holders
InsiderRelationLatest transactionDateShares held
ABBOTT SWATI BARGOTRADirectorStock Award(Grant)Aug 12, 20216,847
CHEN CHRISTOPHER JDirectorStock Award(Grant)Aug 12, 20212,911
FELD PETER A.DirectorStock Award(Grant)Aug 12, 20212,374,800
JOSEPHSON MURAL RDirectorStock Award(Grant)Aug 12, 20212,911
MACKENZIE GREGORY SCOTTDirectorStock Award(Grant)Aug 12, 202110,594
MURRAY JAMES EPresidentConversion of Exercise of derivative securityMar 3, 202110,812

Institution ownership

MGLN institution ownership
Holder% heldSharesValueReported
Blackrock Inc.14.28%3,760,608355.57MSep 29, 2021
Vanguard Group, Inc. (The)9.29%2,447,193231.38MSep 29, 2021
Starboard Value LP9.00%2,369,100224.00MSep 29, 2021
Dimensional Fund Advisors LP5.42%1,427,148134.94MSep 29, 2021
Healthcare of Ontario Pension Plan Trust Fund5.01%1,318,400124.65MSep 29, 2021
Magnetar Financial LLC4.62%1,215,822114.96MSep 29, 2021

Fund ownership

MGLN fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF5.93%1,562,562148.18MOct 30, 2021
Vanguard Total Stock Market Index Fund2.54%669,94063.34MSep 29, 2021
Vanguard Small-Cap Index Fund2.25%591,62155.94MSep 29, 2021
iShares Russell 2000 ETF2.09%551,25952.28MOct 30, 2021
DFA U.S. Small Cap Value Series1.85%487,25746.21MOct 30, 2021
Highland Fds I-NexPoint Merger Arbitrage Fund1.76%464,30643.90MSep 29, 2021
Advertisement